Image Ben Hargreaves Oncology Can CAR-T first movers keep pace in a rapidly evolving marke... The CAR-T landscape has quickly transformed from a pioneering breakthrough to a highly competitive and evolving market. R&D Brain-computer interfaces could redefine precision medicine BCIs could emerge as a ground-breaking tool for the pharma industry, offering new ways to understand and treat complex conditions. Market Access Moderna’s missteps spotlight PMCPA’s role in upholding pharm... The pharmaceutical industry operates under a complex regulatory landscape, balancing government oversight with self-imposed standards. Market Access EMA’s strategy for speeding up drug approvals in the EU The EMA is implementing major changes to accelerate drug approvals in the EU, addressing delays that affect patients and businesses alike Load more results
Oncology Can CAR-T first movers keep pace in a rapidly evolving marke... The CAR-T landscape has quickly transformed from a pioneering breakthrough to a highly competitive and evolving market.
R&D Brain-computer interfaces could redefine precision medicine BCIs could emerge as a ground-breaking tool for the pharma industry, offering new ways to understand and treat complex conditions.
Market Access Moderna’s missteps spotlight PMCPA’s role in upholding pharm... The pharmaceutical industry operates under a complex regulatory landscape, balancing government oversight with self-imposed standards.
Market Access EMA’s strategy for speeding up drug approvals in the EU The EMA is implementing major changes to accelerate drug approvals in the EU, addressing delays that affect patients and businesses alike
News NHS "isn't delivering equitable care for rare diseases" A Genetic Alliance UK report claims the NHS is failing to meet the needs of many of the 3.5 million people in the country who live with rare diseases.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
